Texas Pharmacy Warned on Sterility and More GMP Violations

Drug Industry Daily
A A
A complaint about ineffective erectile dysfunction drugs led to an FDA inspection of a Texas-based compounder, resulting in a lengthy warning letter from the agency detailing sterility concerns.

To View This Article:

Login

Subscribe To Drug Industry Daily